Latest Veterinary Therapeutics News

Page 1 of 1

Argent BioPharma Cuts US$5.5m Debt with Splash Licensing Deal, Advances Veterinary Assets

Argent BioPharma has eliminated US$5.5 million in secured debt through a global licensing agreement for its CannEpil® epilepsy therapy, while completing a key acquisition and advancing clinical trials in veterinary therapeutics.

Ada Torres

28 July 2026

Top